These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31951186)

  • 21. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis].
    Hayashi N; Kumagai S
    Rinsho Byori; 2010 May; 58(5):466-79. PubMed ID: 20560456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
    Lamerato L; Price K; Szymialis R; Eaddy M; Ogbonnaya A; Shih HC; Ahmad H
    J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
    Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G
    Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoantibodies in the diagnosis of rheumatoid arthritis. Utility of anti-cyclic citrullinated peptides].
    Ruiz-Alegría C; López-Hoyos M
    Med Clin (Barc); 2003 Nov; 121(16):619-24. PubMed ID: 14636538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: A meta-analysis.
    Lee YH; Bae SC; Song GG
    Z Rheumatol; 2015 Dec; 74(10):911-8. PubMed ID: 26111961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of autoantibodies combined detection for rheumatoid arthritis.
    Sun P; Wang W; Chen L; Li N; Meng X; Bian J; Yang J; Wang X; Zhu W; Ming L
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27800636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis.
    Kobak S; Ylmaz H; Sever F; Duran A; Sen N
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):206-10. PubMed ID: 25363220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis.
    Vittecoq O; Incaurgarat B; Jouen-Beades F; Legoedec J; Letourneur O; Rolland D; Gervasi G; Ménard JF; Gayet A; Fardellone P; Daragon A; Jolivet M; le Loët X; Tron F
    Clin Exp Immunol; 2004 Jan; 135(1):173-80. PubMed ID: 14678280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
    Zengin O; Yıldız H; Demir ZH; Dağ MS; Aydınlı M; Onat AM; Kısacık B
    Adv Clin Exp Med; 2017 Sep; 26(6):987-990. PubMed ID: 29068601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
    Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
    Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
    Cho SY; Kang SY; Lee HJ; Lee WI
    Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T; Feng L
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
    Alexiou I; Germenis A; Ziogas A; Theodoridou K; Sakkas LI
    BMC Musculoskelet Disord; 2007 Apr; 8():37. PubMed ID: 17448247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
    Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.